A Patient’s Journey Through Various Life Stages with Severe Hemophilia

Release date: April 30, 2014
Expiration date: October 31, 2015
Estimated Time to Complete Activity: 0.75 CME, 0.7 CNE, and 0.75 CPE hours
Compatible with (IE 6 and up, Firefox, Safari)

Distinguished Faculty Presenters


	Marion Koerper, MD Professor Emerita on Recall Department of Pediatric Hematology School of Medicine University of California, San Francisco (UCSF) School of Medicine Medical Advisor National Hemophilia Foundation Click here for biography


	Jennifer Maahs, RN, PNP, MSN Nurse Practitioner Indiana Hemophilia and Thrombosis Center Click here for biography

	Celynda G. Tadlock, PharmD, MBA Chief Operating Officer, Pharmacy Coventry Health Care Click here for biography

Target Audience

Medical Directors and Pharmacy Directors from health plans, HMOs, integrated health systems, employers, quality organizations, and other managed care organizations (MCOs)
Managed care-affiliated care team members involved with patient evaluation, education, and follow-up for hemophilia patients including: physicians, pharmacists, registered nurses, and case managers

STATEMENT OF NEED/PROGRAM OVERVIEW

Hemophilia is an expensive chronic condition with total annual costs that can average $250,000 or more for severe patients. Optimal outcomes requires a collaborative and coordinated patient experience throughout various life stages. This case scenario, joint sponsored by the National Hemophilia Foundation, will emphasize the need for well-coordinated treatment management, the importance of understanding effective ways of using available treatments, and the importance of collaboration among all stakeholders as a patient journeys through his life with severe hemophilia.

EDUCATIONAL OBJECTIVES
After completing this activity, the participant should be better able to:

Discuss the impact of hemophilia with and without inhibitors on clinical, economic, and humanistic outcomes
Employ collaborative care strategies and resources, including HTCs, to improve care coordination for health plan patients with hemophilia
Provide appropriate care and counsel for patients and their families.
Provide accurate and appropriate counsel as part of the treatment team

ACCREDITATION

Physician Accreditation Statement
This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education through the joint sponsorship of Postgraduate Institute for Medicine and Impact Education, LLC. Postgraduate Institute for Medicine is accredited by the ACCME to provide continuing medical education for physicians.

Credit Designation
Postgraduate Institute for Medicine designates this enduring material for a maximum of 0.75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Pharmacist Accreditation Statement


	Postgraduate Institute for Medicine is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

Credit Designation
Postgraduate Institute for Medicine designates this continuing education activity for 0.75 contact hours (0.75 CEUs) of the Accreditation Council for Pharmacy Education.
(Universal Activity Number – 0809-9999-14-144-H01-P)

Upon receipt of the completed activity evaluation form, transcript information will be available at www.mycpemonitor.net within 4 weeks.

Type of Activity
Knowledge

Nursing Accreditation Statement

Credit Designation
This educational activity for 0.7 contact hours is provided by Postgraduate Institute for Medicine.

Accreditation Statement
Postgraduate Institute for Medicine is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.

Disclosure of Conflicts of Interest
Postgraduate Institute for Medicine (PIM) requires instructors, planners, managers and other individuals who are in a position to control the content of this activity to disclose any real or apparent conflict of interest (COI) they may have as related to the content of this activity. All identified COI are thoroughly vetted and resolved according to PIM policy. PIM is committed to providing its learners with high quality CME activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of a commercial interest.

The faculty reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CE activity:

*Name of Faculty or Presenter*	*Reported Financial Relationship*
Marion A. Koerper, MD	Consulting Fees: Baxter, Bayer
Jennifer Maahs, RN, PNP, MSN	Consulting Fees: Baxter, Biogen Idec, and Novo Nordisk, Inc.
Celynda Tadlock, PharmD, MBA	Has nothing to disclose

The planners and managers reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CE activity:

*Name of Planner or Manager*	*Reported Financial Relationship*
Steven Casebeer, MBA	No financial interest/relationships relating to the topic of this activity
The following PIM planners and managers, Laura Excell, ND, NP, MS, MA, LPC, NCC, Trace Hutchison, PharmD, Samantha Mattiucci, PharmD, CCMEP, and Jan Schultz, RN, MSN, CCMEP, hereby state that they or their spouse/life partner do not have any financial relationships or relationships to products or devices with any commercial interest related to the content of this activity of any amount during the past 12 months.

Disclosure of Unlabeled Use
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications.

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Disclaimer
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

Fee Information
There is no fee for this educational activity.